Pancreatic Cancer Research

ResearcherUniversity of KochiActive in the last 2 years

Keisuke Taniuchi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9165-7494; OpenAlex author ID A5058246420. Sources: OpenAlex.

Their work

Papers
23 (first author 4, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
15
Papers, trials and grants by year

2011: 2 papers · 2012: 2 papers · 2013: none · 2014: 3 papers · 2015: 1 paper · 2016: 2 papers · 2017: 1 paper · 2018: 2 papers · 2019: 3 papers · 2020: 1 paper · 2021: none · 2022: 2 papers · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 2 papers

Papers 23

  1. Chemotherapy-induced CAF-associated stromal remodeling in a humanized stroma pancreatic ductal adenocarcinoma organoid xenograft model: a comparison between GP… Last author DOI 10.1007/s13577-026-01443-8↗
  2. Inhibition of pancreatic cancer growth by an siRNA targeting SNORA22 and a folic acid-conjugated cationic oligopeptide. Last author DOI 10.1007/s13577-026-01458-1↗
  3. Inhibitory effects of the combination of rapamycin with gemcitabine plus paclitaxel on the growth of pancreatic cancer tumors. Last author DOI 10.1007/s13577-024-01165-9↗
  4. Correction: KHSRP-bound small nucleolar RNAs associate with promotion of cell invasiveness and metastasis of pancreatic cancer. Co-author DOI 10.18632/oncotarget.28361↗
  5. Establishment of a mouse model of pancreatic cancer using human pancreatic cancer cell line S2-013-derived organoid. Last author DOI 10.1007/s13577-022-00684-7↗
  6. Upregulation of PODXL and ITGB1 in pancreatic cancer tissues preoperatively obtained by EUS-FNAB correlates with unfavorable prognosis of postoperative pancrea… Co-author DOI 10.1371/journal.pone.0265172↗
  7. KHSRP-bound small nucleolar RNAs associate with promotion of cell invasiveness and metastasis of pancreatic cancer. Co-author DOI 10.18632/oncotarget.27413↗
  8. Circulating pancreatic cancer exosomal RNAs for detection of pancreatic cancer. First author DOI 10.1002/1878-0261.12398↗
  9. Overexpression of PODXL/ITGB1 and BCL7B/ITGB1 accurately predicts unfavorable prognosis compared to the TNM staging system in postoperative pancreatic cancer p… Co-author DOI 10.1371/journal.pone.0217920↗
  10. Efficient delivery of small interfering RNAs targeting particular mRNAs into pancreatic cancer cells inhibits invasiveness and metastasis of pancreatic tumors. Co-author DOI 10.18632/oncotarget.26880↗
  11. Measurement of serum PODXL concentration for detection of pancreatic cancer. Co-author DOI 10.2147/ott.s155367↗
  12. ARHGEF4 predicts poor prognosis and promotes cell invasion by influencing ERK1/2 and GSK-3α/β signaling in pancreatic cancer. Co-author DOI 10.3892/ijo.2018.4549↗
  13. The transcription factor HOXB7 regulates ERK kinase activity and thereby stimulates the motility and invasiveness of pancreatic cancer cells. First author DOI 10.1074/jbc.m116.772780↗
  14. Vav3 is linked to poor prognosis of pancreatic cancers and promotes the motility and invasiveness of pancreatic cancer cells. First author DOI 10.1016/j.pan.2016.07.002↗
  15. CCDC88A, a prognostic factor for human pancreatic cancers, promotes the motility and invasiveness of pancreatic cancer cells. First author DOI 10.1186/s13046-016-0466-0↗
  16. Peroxiredoxin 1 promotes pancreatic cancer cell invasion by modulating p38 MAPK activity. Co-author DOI 10.1097/mpa.0000000000000270↗
  17. KIF20A-mediated RNA granule transport system promotes the invasiveness of pancreatic cancer cells. Co-author DOI 10.1016/j.neo.2014.10.007↗
  18. IGF2BP3-mediated translation in cell protrusions promotes cell invasiveness and metastasis of pancreatic cancer. Co-author DOI 10.18632/oncotarget.2257↗
  19. RUVBL1 directly binds actin filaments and induces formation of cell protrusions to promote pancreatic cancer cell invasion. Co-author DOI 10.3892/ijo.2014.2380↗
  20. BART inhibits pancreatic cancer cell invasion by PKCα inactivation through binding to ANX7. Co-author DOI 10.1371/journal.pone.0035674↗
  21. BART inhibits pancreatic cancer cell invasion by Rac1 inactivation through direct binding to active Rac1. Co-author DOI 10.1593/neo.12352↗
  22. Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growth. Co-author DOI 10.1038/onc.2011.194↗
  23. BART inhibits pancreatic cancer cell invasion by inhibiting ARL2-mediated RhoA inactivation. Co-author DOI 10.3892/ijo.2011.1156↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mutsuo Furihata · 12 shared papers, 2014–2026 · strength 1.56
  2. Toshiji Saibara · 15 shared papers, 2011–2019 · strength 1.14
  3. Kaoru Furihata · 4 shared papers, 2022–2026 · strength 1.12
  4. Mitsunari Ogasawara · 4 shared papers, 2020–2023 · strength 0.95
  5. Makiko Tsuboi · 5 shared papers, 2016–2019 · strength 0.49
  6. Yuri Jobu · 1 shared paper, 2025 · strength 0.30
  7. Kazuhiro Hiyama · 1 shared paper, 2026 · strength 0.30
  8. Kazuhiro Hanazaki · 4 shared papers, 2014–2016 · strength 0.22
  9. Hideki Taniguchi · 1 shared paper, 2022 · strength 0.16
  10. Chiharu Tanaka · 1 shared paper, 2022 · strength 0.16
  11. Makoto Ueno · 1 shared paper, 2022 · strength 0.16
  12. Takehiro Okabayashi · 1 shared paper, 2019 · strength 0.11
  13. Tatsuya Kitagawa · 1 shared paper, 2019 · strength 0.11
  14. Aki Tanouchi · 2 shared papers, 2011–2016 · strength 0.08
  15. Michael Anthony Hollingsworth · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.